References
- Krajinovic M, Lamothe S, Labuda D, . Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 2004;103:252–257.
- Pombo-de-Oliveira MS, Koifman S. Infant acute leukemia and maternal exposures during pregnancy. Cancer Epidemiol. Biomarkers Prev 2006;15:2336–2341.
- Hein DW, Doll MA, Fretland AJ, . Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol. Biomarkers Prev 2000;9:29–42.
- Garcia-Closas M, Malats N, Silverman D, . NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 2005;366:649–659.
- Jiao L, Doll MA, Hein DW, . Haplotype of N-acetyltransferase 1 and 2 and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2007;16:2379–2386.
- Lemos MC, Cabrita FJ, Silva HA, . Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias. Carcinogenesis 1999;20:1225–1229.
- Majumdar S, Mondal BC, Ghosh M, . Association of cytochrome P450, glutathione S-transferase and N-acetyl transferase 2 gene polymorphisms with incidence of acute myeloid leukemia. Eur J Cancer Prev 2008;17:125–132.
- Krajinovic M, Richer C, Sinnett H, . Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 2000;9:557–562.
- Zanrosso CW, Emerenciano M, Goncalves BA, . N-acetyltransferase 2 polymorphisms and susceptibility to infant leukemia with maternal exposure to dipyrone during pregnancy. Cancer Epidemiol Biomarkers Prev 2010;19:3037–3043.
- de Souza Reis R Sr, de Camargo B, de Oliveira Santos M, . Childhood leukemia incidence in Brazil according to different geographical regions. Pediatr Blood Cancer 2011;56:58–64.
- Parra FC, Amado RC, Lambertucci JR, . Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA 2003;100:177–182.
- Cascorbi I, Brockmoller J, Mrozikiewicz PM, . Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer. Cancer Res 1996;56:3961–3966.
- Hein DW, Boukouvala S, Grant DM, . Changes in consensus arylamine N-acetyltransferase gene nomenclature. Pharmacogenet Genomics 2008;18:367–368.
- Vatsis KP, Weber WW, Bell DA, . Nomenclature for N-acetyltransferases. Pharmacogenetics 1995;5:1–17.
- Possuelo LG, Castelan JA, de Brito TC, . Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil. Eur J Clin Pharmacol 2008;64:673–681.
- Teixeira RL, Miranda AB, Pacheco AG, . Genetic profile of the arylamine N-acetyltransferase 2 coding gene among individuals from two different regions of Brazil. Mutat Res 2007;624:31–40.
- Bailliet G, Santos MR, Alfaro EL, . Allele and genotype frequencies of metabolic genes in Native Americans from Argentina and Paraguay. Mutat Res 2007;627:171–177.
- Rollinson S, Roddam P, Willett E, . NAT2 acetylator genotypes confer no effect on the risk of developing adult acute leukemia: a case-control study. Cancer Epidemiol Biomarkers Prev 2001;10:567–568.
- Perera FP, Jedrychowski W, Rauh V, . Molecular epidemiologic research on the effects of environmental pollutants on the fetus. Environ Health Perspect 1999;107:451–460.
- Greaves M. Childhood leukaemia. BMJ 2002;324:283–287.